Patents by Inventor Thomas Delonge
Thomas Delonge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11887696Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.Type: GrantFiled: November 20, 2018Date of Patent: January 30, 2024Assignee: DEEP GENOMICS INCORPORATEDInventors: Brendan Frey, Michael K. K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
-
Patent number: 11769073Abstract: Methods and systems for expanding a training set of one or more original biological sequences are provided. An original training set is obtained, wherein the original training set comprises one or more original biological sequences. Saliency values corresponding to one or more elements in each of the one or more original biological sequences are obtained. For each of the original biological sequences, one or more modified biological sequences are produced and the one or more modified biological sequences are associated with the original biological sequence. One or more elements are generated in each of the one or more modified biological sequences using one or more elements in the associated original biological sequence and the corresponding saliency values. The one or more modified biological sequences for each of the original biological sequences are added to the original training set to form an expanded training set.Type: GrantFiled: November 2, 2018Date of Patent: September 26, 2023Assignee: DEEP GENOMICS INCORPORATEDInventors: Brendan John Frey, Andrew Thomas DeLong, Hui Yuan Xiong
-
Publication number: 20210383890Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.Type: ApplicationFiled: July 7, 2021Publication date: December 9, 2021Inventors: Brendan FREY, Michael K. K. LEUNG, Andrew Thomas DELONG, Hui Yuan XIONG, Babak ALIPANAHI, Leo J. LEE, Hannes BRETSCHNEIDER
-
Publication number: 20190252041Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.Type: ApplicationFiled: November 20, 2018Publication date: August 15, 2019Inventors: Brendan Frey, Michael K.K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
-
Publication number: 20190073443Abstract: Methods and systems for expanding a training set of one or more original biological sequences are provided. An original training set is obtained, wherein the original training set comprises one or more original biological sequences. Saliency values corresponding to one or more elements in each of the one or more original biological sequences are obtained. For each of the original biological sequences, one or more modified biological sequences are produced and the one or more modified biological sequences are associated with the original biological sequence. One or more elements are generated in each of the one or more modified biological sequences using one or more elements in the associated original biological sequence and the corresponding saliency values. The one or more modified biological sequences for each of the original biological sequences are added to the original training set to form an expanded training set.Type: ApplicationFiled: November 2, 2018Publication date: March 7, 2019Inventors: Brendan John Frey, Andrew Thomas DeLong, Hui Yuan Xiong
-
Patent number: 10185803Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.Type: GrantFiled: June 15, 2015Date of Patent: January 22, 2019Assignee: DEEP GENOMICS INCORPORATEDInventors: Brendan Frey, Michael K. K. Leung, Andrew Thomas Delong, Hui Yuan Xiong, Babak Alipanahi, Leo J. Lee, Hannes Bretschneider
-
Publication number: 20180118801Abstract: Disclosed are compositions and methods for detecting, isolating, and/or characterizing a T cell or autoantibody associated with type I diabetes. The composition and methods comprise the use of a hybrid insulin peptide having an N-terminal amino acid sequence taken from the human insulin peptide and a C-terminal amino acid sequence taken from a secretory granule protein that are joined through a peptide bond to form an autoimmune antigen. The detecting, isolating and characterization step further includes performing an immunoassay and/or T cell proliferation assay with the disclosed hybrid insulin peptides, where preferably, the immunoassay is an ELISPOT assay.Type: ApplicationFiled: September 5, 2017Publication date: May 3, 2018Inventors: Thomas DELONG, Kathryn HASKINS
-
Publication number: 20160364522Abstract: Described herein are systems and methods that receive as input a DNA or RNA sequence, extract features, and apply layers of processing units to compute one ore more condition-specific cell variables, corresponding to cellular quantities measured under different conditions. The system may be applied to a sequence containing a genetic variant, and also to a corresponding reference sequence to determine how much the condition-specific cell variables change because of the variant. The change in the condition-specific cell variables are used to compute a score for how deleterious a variant is, to classify a variant's level of deleteriousness, to prioritize variants for subsequent processing, and to compare a test variant to variants of known deleteriousness.Type: ApplicationFiled: June 15, 2015Publication date: December 15, 2016Inventors: Brendan FREY, Michael K.K. LEUNG, Andrew Thomas DELONG, Hui Yuan XIONG, Babak ALIPANAHI, Leo J. LEE, Hannes BRETSCHNEIDER
-
Patent number: 9165147Abstract: An apparatus and a method are arranged for generating a digital image. The apparatus comprises an image generation unit for generating the digital image having a first security module adapted for cryptographically linking a first secret unambiguously identifying the first security module, and securely deposited therein, with the digital image such that the integrity of the digital image can be ascertained using the result of this cryptographic linkage. Further, the apparatus comprises a portable data carrier which can be introduced into the apparatus. The portable data carrier is furnished with a second security module which is adapted for cryptographically linking a second secret unambiguously identifying the portable data carrier, and securely deposited therein, with the digital image such that the identity of the portable data carrier can be ascertained using the result of this cryptographic linkage.Type: GrantFiled: December 19, 2012Date of Patent: October 20, 2015Assignee: GIESECKE & DEVRIENT GMBHInventors: Andreas Johne, Thomas Delonge
-
Publication number: 20140321640Abstract: An apparatus and a method are arranged for generating a digital image. The apparatus comprises an image generation unit for generating the digital image having a first security module adapted for cryptographically linking a first secret unambiguously identifying the first security module, and securely deposited therein, with the digital image such that the integrity of the digital image can be ascertained using the result of this cryptographic linkage. Further, the apparatus comprises a portable data carrier which can be introduced into the apparatus. The portable data carrier is furnished with a second security module which is adapted for cryptographically linking a second secret unambiguously identifying the portable data carrier, and securely deposited therein, with the digital image such that the identity of the portable data carrier can be ascertained using the result of this cryptographic linkage.Type: ApplicationFiled: December 19, 2012Publication date: October 30, 2014Applicant: GIESECKE & DEVRIENT GMBHInventors: Andreas Johne, Thomas Delonge
-
Publication number: 20120128646Abstract: The present invention is related to the development and treatment of autoimmune disease. Autoimmune diseases can result from tissue damage caused by the activation of autoreactive T cells by autoantigens. For example, peptide fragments of naturally occurring proteins (i.e., for example, chromogranin A) may activate autoreactive T cells that result in the destruction of pancreatic ? islet cells, possibly by the release of inflammatory cytokines (i.e., for example, interferon-?). One naturally occurring biologically active chromogranin A peptide fragment, WE14, may comprise a diabetogenic autoantigen. Truncation and extension analysis of WE14 indicates that the stimulating binding register of WE14 occupies only half of the mouse IAg7 peptide binding groove, leaving positions p1 to p4 empty.Type: ApplicationFiled: February 16, 2010Publication date: May 24, 2012Inventors: Kathryn Haskins, Thomas Delong, John W. Kappler, Brian Stadinski, Nichole Reisdorph, Rick Reisdorph
-
Publication number: 20060226606Abstract: A playing field is used with a drinking game involving a plurality of cups. It has a playing surface with a means for maintaining the playing surface in a horizontal position. The playing surface is disposed on a planar member and has cup-receiving recesses. In some embodiments, the playing field is a planar member that rests upon a table, while in other embodiments the playing field is a table. The planar member may have first and second portions that are joined along an edge of each portion. The playing surface may be adapted for illumination from at least one light source positioned below the playing surface. A raised edge may be provided around a periphery of the playing surface, especially with a plurality of cup-receiving recesses along each of a pair of opposing sides of the playing surface.Type: ApplicationFiled: April 11, 2006Publication date: October 12, 2006Applicant: LIQUID GAMES LLCInventors: Scott FINLEY, Thomas DELONG, Kurt DOLL
-
Patent number: 5572328Abstract: An optical detector for use in liquid chromatography systems or capillary electrophoresis systems comprises an optically transparent detector body through which an analyte channel extends, a fluid containing the analyte being adapted to be guided through said analyte channel. In order to increase the detection sensitivity, the light path between a light source introducing light and an optoelectric sensor element of the liquid chromatography system or capillary electrophoresis system is constructed as a Bragg waveguide structure extending at least along a sublength of said analyte channel essentially in the channel direction.Type: GrantFiled: February 14, 1995Date of Patent: November 5, 1996Assignee: Hewlett-Packard CompanyInventors: Henning Fouckhardt, Thomas Delonge